Literature DB >> 18640107

Potential artefacts in proteome analysis of plasma of Gaucher patients due to protease abnormalities.

Mariëlle J van Breemen1, Johannes M F G Aerts, Richard R Sprenger, Dave Speijer.   

Abstract

The plasma proteome of type I Gaucher disease patients was investigated by 2D gel electrophoresis (2DGE). Using the classical procedure with 8 M urea treated plasma, several high molecular weight proteins were absent from Gaucher plasma specimens, while additional low molecular weight proteins were visible. The latter were identified as proteolytic degradation products. Adding small amounts of patient plasma to control plasma gave extensive protein breakdown. The presence of 2.2 M thiourea/7.7 M urea in the rehydration solution totally prevented breakdown. In the 'urea only' solution, protease(s) uniquely present in Gaucher plasma, appear to be still active towards other denatured plasma proteins at low pH. Therapy of patients results in gradual disappearance of proteolytic capacity from plasma specimens, indicating it to be related to the presence of Gaucher storage cells. The proteolytic activity could be partly removed from Gaucher plasma samples by Concanavalin A, suggesting that glycoproteins are involved. Reduction of proteolysis by Pepstatin A and Leupeptin implies that cathepsins, proteases known to be overproduced by Gaucher storage cells, are involved. In conclusion, 2DGE Gaucher plasma proteomes should be interpreted cautiously given the abnormal high levels of proteases associated with this disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640107     DOI: 10.1016/j.cca.2008.06.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.

Authors:  Philippe M Campeau; Moutih Rafei; Marie-Noëlle Boivin; Ying Sun; Gregory A Grabowski; Jacques Galipeau
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

Review 2.  Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.

Authors:  Johannes M F G Aerts; Wouter W Kallemeijn; Wouter Wegdam; Maria Joao Ferraz; Marielle J van Breemen; Nick Dekker; Gertjan Kramer; Ben J Poorthuis; Johanna E M Groener; Josanne Cox-Brinkman; Saskia M Rombach; Carla E M Hollak; Gabor E Linthorst; Martin D Witte; Henrik Gold; Gijs A van der Marel; Herman S Overkleeft; Rolf G Boot
Journal:  J Inherit Metab Dis       Date:  2011-03-29       Impact factor: 4.982

3.  Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards.

Authors:  Gertjan Kramer; Yvonne Woolerton; Jan P van Straalen; Johannes P C Vissers; Nick Dekker; James I Langridge; Robert J Beynon; Dave Speijer; Auguste Sturk; Johannes M F G Aerts
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

Review 4.  Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease.

Authors:  Lunawati L Bennett; Kelsey Turcotte
Journal:  Drug Des Devel Ther       Date:  2015-08-18       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.